- Four Cases of Hematologic Malignancy Following Radioactive Iodine Therapy for Thyroid Cancer
-
Im M, Lee JK, Hong YJ, Hong SI, Kang HJ, Na II, Ryoo BY, Cheon GJ, Lee HN, Chang YH
- KMID: 1781576
- Korean J Lab Med.
- 2008 Dec;28(6):425-429.
- doi: 10.3343/kjlm.2008.28.6.425
Ionizing radiation including I131 might produce chromosomal translocation, causing hematologic malignancy. The incidence of leukemia following radioactive iodine treatment for thyroid cancer has been reported to be approximately 0.1 to... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Outcome of Remnant Thyroid Ablation with Low Dose Radioiodine in Korean Patients with Low to Intermediate-risk Thyroid Cancer
-
Ha S, Oh SW, Kim YK, Koo DH, Jung YH, Yi KH, Chung JK
- KMID: 2164471
- J Korean Med Sci.
- 2015 Jul;30(7):876-881.
- doi: 10.3346/jkms.2015.30.7.876
Radioiodine activity required for remnant thyroid ablation is of great concern, to avoid unnecessary exposure to radiation and minimize adverse effects. We investigated clinical outcomes of remnant thyroid ablation with... -
- CITED
-
- Close
- SHARE
-
- Close
- Determination of Urinary Iodine Concentration by Inductively Coupled Plasma-mass Spectrometry in Thyroid Cancer Patients on Low-iodine Diet
-
Lee JH, Ji OJ, Song MJ, Park HD, Kim HK, Kim SW, Chung JH, Lee SY
- KMID: 1781640
- Korean J Lab Med.
- 2010 Aug;30(4):351-356.
- doi: 10.3343/kjlm.2010.30.4.351
BACKGROUND: Thyroid cancer patients should be on low-iodine diet (LID) before radioactive iodine therapy (RAIT) to maximize the effect of RAIT. Urinary iodine excretion is the most accurate marker of... -
- CITED
-
- Close
- SHARE
-
- Close
